Literature DB >> 23929983

Introductory Chemistry: A Molar Relaxivity Experiment in the High School Classroom.

Anna C Dawsey1, Kathryn L Hathaway, Susie Kim, Travis J Williams.   

Abstract

Dotarem and Magnevist, two clinically available magnetic resonance imaging (MRI) contrast agents, were assessed in a high school science classroom with respect to which is the better contrast agent. Magnevist, the more efficacious contrast agent, has negative side effects because its gadolinium center can escape from its ligand. However, Dotarem, though a less efficacious contrast agent, is a safer drug choice. After the experiment, students are confronted with the FDA warning on Magnevist, which enabled a discussion of drug efficacy versus safety. We describe a laboratory experiment in which NMR spin lattice relaxation rate measurements are used to quantify the relaxivities of the active ingredients of Dotarem and Magnevist. The spin lattice relaxation rate gives the average amount of time it takes the excited nucleus to relax back to the original state. Students learn by constructing molar relaxivity curves based on inversion recovery data sets that Magnevist is more relaxive than Dotarem. This experiment is suitable for any analytical chemistry laboratory with access to NMR.

Entities:  

Keywords:  Analytical Chemistry; Applications of Chemistry; Drugs/Pharmaceutical; First-Year Undergraduate/General; Hands-On Learning/Manipulative; High School/Introductory Chemistry; Laboratory Instruction; NMR Spectroscopy; Second-Year Undergraduate

Year:  2013        PMID: 23929983      PMCID: PMC3733391          DOI: 10.1021/ed3006902

Source DB:  PubMed          Journal:  J Chem Educ        ISSN: 0021-9584            Impact factor:   2.979


  15 in total

Review 1.  Next generation, high relaxivity gadolinium MRI agents.

Authors:  Kenneth N Raymond; Valérie C Pierre
Journal:  Bioconjug Chem       Date:  2005 Jan-Feb       Impact factor: 4.774

Review 2.  Magnetic resonance contrast agents: from the bench to the patient.

Authors:  Vito Lorusso; Lorella Pascolo; Cristina Fernetti; Pier Lucio Anelli; Fulvio Uggeri; Claudio Tiribelli
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

3.  Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA).

Authors:  Christoph U Herborn; Elmar Honold; Michael Wolf; Jörn Kemper; Sonja Kinner; Gerhard Adam; Jörg Barkhausen
Journal:  Invest Radiol       Date:  2007-01       Impact factor: 6.016

4.  Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Authors:  Thomas Grobner
Journal:  Nephrol Dial Transplant       Date:  2006-01-23       Impact factor: 5.992

Review 5.  Classification and basic properties of contrast agents for magnetic resonance imaging.

Authors:  Carlos F G C Geraldes; Sophie Laurent
Journal:  Contrast Media Mol Imaging       Date:  2009 Jan-Feb       Impact factor: 3.161

6.  Nephrogenic systemic fibrosis and gadolinium: a perfect storm.

Authors:  Patrick M Colletti
Journal:  AJR Am J Roentgenol       Date:  2008-10       Impact factor: 3.959

7.  Structure - relaxivity relationships among targeted MR contrast agents.

Authors:  Peter Caravan; Zhaoda Zhang
Journal:  Eur J Inorg Chem       Date:  2012-04       Impact factor: 2.524

8.  Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned.

Authors:  Dale R Broome; Mark S Girguis; Pedro W Baron; Alfred C Cottrell; Ingrid Kjellin; Gerald A Kirk
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

9.  Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.

Authors:  Peter Marckmann; Lone Skov; Kristian Rossen; Anders Dupont; Mette Brimnes Damholt; James Goya Heaf; Henrik S Thomsen
Journal:  J Am Soc Nephrol       Date:  2006-08-02       Impact factor: 10.121

10.  Nephrogenic gadolinium biodistribution and skin cellularity following a single injection of Omniscan in the rat.

Authors:  John Haylor; Anne Dencausse; Melissa Vickers; Faith Nutter; Gaelle Jestin; David Slater; Jean-Marc Idee; Sameh Morcos
Journal:  Invest Radiol       Date:  2010-09       Impact factor: 6.016

View more
  1 in total

1.  Targeted Gold Nanoparticle⁻Oligonucleotide Contrast Agents in Combination with a New Local Voxel-Wise MRI Analysis Algorithm for In Vitro Imaging of Triple-Negative Breast Cancer.

Authors:  Rajat Chauhan; Nagwa El-Baz; Robert S Keynton; Kurtis T James; Danial A Malik; Mingming Zhu; Ayman El-Baz; Chin K Ng; Paula J Bates; Mohammad Tariq Malik; Martin G O'Toole
Journal:  Nanomaterials (Basel)       Date:  2019-05-07       Impact factor: 5.076

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.